Department of Oncology, GanJiang New Area Hospitalof, First Affiliated Hospital of NanChang University, NanChang, Jiangxi, 330117, People's Republic of China.
Department of Oncology, the First Affiliated Hospital of NanChang University, NanChang, Jiangxi, 330006, People's Republic of China.
J Egypt Natl Canc Inst. 2024 Sep 23;36(1):29. doi: 10.1186/s43046-024-00234-2.
We explored the dosimetric efficacy of the abdominal deep inspiration breath hold (aDIBH) technique using an audio-guided device in patients with left breast cancer undergoing postoperative adjuvant radiotherapy compared to free breathing (FB).
A total of 35 patients with early stage left breast cancer underwent two computed tomography simulation scans each with aDIBH and FB after breast-conserving surgery. Treatment planning was optimized using the Pinnacle 9.10 planning system. The heart, left anterior descending coronary artery (LADCA), and left lung was defined as organs at risk (OARs). The dosimetric differences in the planning target volume (PTV) and OARs were compared between aDIBH and FB.
Compared with FB, the heart moved farther caudally and away from the chest wall, and the volume of heart became smaller under aDIBH due to expansion of the lungs. The D mean of the heart, LADCA and left lung of aDIBH were respectively reduced by 332.79 ± 264.61 cGy (P < 0.001), 1290.37 ± 612.09 cGy (P < 0.047) and 69.94 ± 117.73 cGy (P < 0.001). The V20 and V30 of the OARs were also significantly reduced with statistical differences (P < 0.05). In addition, there was no significant difference in the dosimetric parameters of the PTV between the two groups (P > 0.05).
Implementation of the aDIBH technique for postoperative radiotherapy after breast-conserving surgery of the left breast cancer could reduce irradiation of the heart dose, LADCA dose and left lung dose, without compromising target coverage.
我们探索了在接受保乳术后辅助放疗的左侧乳腺癌患者中,使用音频引导设备的腹部深吸气屏气(aDIBH)技术与自由呼吸(FB)相比的剂量学效果。
共 35 例早期左侧乳腺癌患者,在保乳手术后,分别在 FB 和 aDIBH 下进行两次 CT 模拟扫描。使用 Pinnacle 9.10 计划系统对治疗计划进行优化。将心脏、左前降支冠状动脉(LADCA)和左肺定义为危及器官(OARs)。比较了 aDIBH 和 FB 下计划靶区(PTV)和 OAR 的剂量学差异。
与 FB 相比,aDIBH 下肺的扩张导致心脏更靠尾侧和远离胸壁,心脏的体积变小。aDIBH 下心、LADCA 和左肺的 Dmean 分别减少了 332.79 ± 264.61 cGy(P<0.001)、1290.37 ± 612.09 cGy(P<0.047)和 69.94 ± 117.73 cGy(P<0.001)。OAR 的 V20 和 V30 也显著降低,具有统计学差异(P<0.05)。此外,两组 PTV 的剂量学参数无显著差异(P>0.05)。
在左侧乳腺癌保乳术后放疗中实施 aDIBH 技术可以降低心脏剂量、LADCA 剂量和左肺剂量,同时不影响靶区覆盖。